Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.101888
Revised: November 7, 2024
Accepted: December 2, 2024
Published online: February 15, 2025
Processing time: 110 Days and 14.1 Hours
Core Tip: A study by Zhang et al developed a neural network-based predictive model for estimating doses to uninvolved liver tissue during stereotactic body radiation therapy (RT), representing a significant advancement in personalizing RT for liver cancer patients. The model demonstrated high predictive accuracy, with R-values exceeding 0.8, highlighting its potential to standardize dose estimation and improve patient safety by reducing biases. The study's relatively small patient cohort (114 patients) raises concerns about selection bias and limits the model's generalizability. Future research should involve larger multicenter cohorts and a more comprehensive cohort of patient characteristics to improve the generalizability of models and clinical relevance. Interdisciplinary collaboration among oncologists, data scientists, and radiation technologists is vital for improving predictive models and the efficacy and precision of cancer treatment.
